SCPX stock down 98.00% intraday 22 Jan 2026: key levels for traders
SCPX stock plunged 98.00% intraday to USD 0.0002 on 22 Jan 2026 on the AMEX in the United States. The collapse followed heavy selling after the market opened, with volume at 2,981.00 shares, below the 50-day average of 15,019.00. We treat this move as a liquidity-driven collapse that magnified tiny nominal price swings into a headline drop. Traders should note the stock’s tiny market cap of $2,478.00 and extreme dispersion between the year high of $0.35 and today’s price.
SCPX stock intraday price action and volume
SCPX stock fell from an open of USD 0.0005 to a day low of USD 0.0002, a move showing a -98.00% intraday change versus the previous close of USD 0.01. Volume totaled 2,981.00 shares, roughly 0.20x the average volume. Low liquidity means small orders pushed the price sharply lower, a common pattern in microcap biotech names.
What likely drove the top losers move in SCPX stock
We see three drivers behind the sell-off: extremely low market cap and float, recent dilution or share overhang, and sparse trading that magnifies redemptions. There were no major public corporate filings linked to the drop in the immediate window, and major news feeds show limited fresh company updates source and market pages source.
Financial and valuation snapshot for Scorpius Holdings, Inc. (SCPX)
Scorpius Holdings, Inc. trades on AMEX in the United States and shows a market cap of $2,478.00 with 12,387,700.00 shares outstanding. Reported EPS is 43.00, but the price-earnings metric is not meaningful given accounting distortions and negative operating metrics. The company lists as Healthcare, Biotechnology and shows extreme leverage ratios and negative book value per share in recent filings.
Meyka AI grades, technical indicators and model forecast for SCPX stock
Meyka AI rates SCPX with a score of 66.97 out of 100 (Grade B, SUGGESTION: HOLD). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Technicals show RSI near 46.80 and ADX 38.91, indicating a strong trend into the downside. Meyka AI’s forecast model projects a conservative 12-month base case price of USD 0.0001, a bear at USD 0.00005, and a high-risk bull at USD 0.00100. Versus the current price of USD 0.0002, the base case implies -50.00% downside and the bull implies +400.00% upside. Forecasts are model-based projections and not guarantees.
Analyst view, price targets and trading levels for SCPX stock
Third-party ratings show a mixed profile with a C company rating and a Sell recommendation dated 2026-01-16. For active traders, immediate resistance sits near USD 0.0005 and stop-losses should account for wide spreads. Suggested price targets: bear USD 0.00005, base USD 0.00010, and bull USD 0.00100 — each reflects high idiosyncratic risk and low liquidity.
Risks, sector context and trading considerations for SCPX stock
Scorpius operates in Biotechnology within Healthcare; sector moves often affect microcaps. Key risks include capital raises, dilution, extremely low current liquidity, and accounting volatility. We recommend position sizing limits, limit orders, and avoiding market orders. For longer-term investors, watch cash runway and upcoming earnings or operational updates that could change fundamentals.
Final Thoughts
Key takeaways on SCPX stock: the intraday -98.00% collapse to USD 0.0002 on 22 Jan 2026 reflects microcap illiquidity more than typical brownfield operational failure. Our view is cautious. Meyka AI’s quantitative grade assigns SCPX a 66.97/100 (Grade B, HOLD) after factoring sector performance, growth, key metrics, and analyst inputs. The model projects a base case near USD 0.0001 (implied -50.00%), a bear at USD 0.00005 (implied -75.00%) and a high-risk bull at USD 0.00100 (implied +400.00%). These forecasts are model-based projections and not guarantees. Traders should treat SCPX as a speculative, high-volatility name on the AMEX in the United States in USD, limit exposure, and monitor filings and volume closely. For a live quote and order routing, see our platform page for SCPX on Meyka AI SCPX on Meyka.
FAQs
Why did SCPX stock fall 98.00% intraday?
The 98.00% intraday fall reflects extremely low liquidity and a small market cap of USD 2,478.00. Small sell orders pushed the price down steeply. There were no major public operational announcements tied directly to the drop.
What is Meyka AI’s forecast for SCPX stock?
Meyka AI’s forecast model projects a base case of USD 0.0001 and a bull of USD 0.00100 versus the current USD 0.0002. These model-based numbers imply a potential -50.00% downside or +400.00% upside, not guarantees.
How should traders manage risk with SCPX stock?
Use strict position limits, prefer limit orders, and avoid market orders due to wide spreads. Monitor volume, filings, and any capital raise notices. Treat SCPX as a speculative microcap with high dilution risk.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
